137 related articles for article (PubMed ID: 3128970)
1. Plasma concentrations of unbound valproate and the management of epilepsy.
Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Aust N Z J Med; 1987 Dec; 17(6):574-9. PubMed ID: 3128970
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
Yu HY
Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
Knott C; Hamshaw-Thomas A; Reynolds F
Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
[TBL] [Abstract][Full Text] [Related]
4. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
5. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate: dose-plasma level relationships and interdose fluctuations.
Vajda FJ; Mihaly GW; Miles JL; Morris PM; Bladin PF
Clin Exp Neurol; 1978; 15():145-53. PubMed ID: 386306
[TBL] [Abstract][Full Text] [Related]
7. Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics.
Vajda FJ; Drummer OH; Morris PM; McNeil JJ; Bladin PF
Clin Exp Pharmacol Physiol; 1978; 5(1):67-73. PubMed ID: 346272
[TBL] [Abstract][Full Text] [Related]
8. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring.
Johannessen Landmark C; Farmen AH; Burns ML; Baftiu A; Lossius MI; Johannessen SI; Tomson T
Epilepsy Res; 2018 Mar; 141():31-37. PubMed ID: 29453075
[TBL] [Abstract][Full Text] [Related]
10. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
Dutta S; Faught E; Limdi NA
J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of sodium valproate in childhood epilepsy.
McQueen JK; Blackwood DH; Minns RA; Brown JK
Scott Med J; 1982 Oct; 27(4):312-7. PubMed ID: 6815799
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of valproate during maintenance therapy in epileptic children.
Lundberg B; Nergårdh A; Boréus LO
J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
[TBL] [Abstract][Full Text] [Related]
13. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy.
Lenn NJ; Robertson M
Neurology; 1992 May; 42(5):988-90. PubMed ID: 1579255
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of sodium valproate: their clinical value.
Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
Ann Neurol; 1983 Jul; 14(1):38-42. PubMed ID: 6412620
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein binding.
Yu HY; Shen YZ
Biopharm Drug Dispos; 1996 Apr; 17(3):237-47. PubMed ID: 8983398
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate (Epilim) in epilepsy: a trial.
Briant RH; Foote SE; Wallis WE
N Z Med J; 1978 Dec; 88(626):479-82. PubMed ID: 105332
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
